Search clinical trials for: Venlafaxine-XR

Total 693 results

Wake Forest University Health Sciences
University of South Florida; National Institute on Aging (NIA)

Recruiting

Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction (Met-PEF)

Heart Failure With Preserved Ejection Fraction

United States
Sarah Morrow

Recruiting

Adderall XR and Cognitive Impairment in MS

Multiple Sclerosis

Canada
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Diabetes Mellitus, Type II
Aarhus University Hospital

Completed

Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure (METRONOME)

Heart Failure, Systolic

Denmark
University of Pennsylvania
National Institute of Mental Health (NIMH)

Completed

Antidepressant Therapy in Treating Bipolar Type II Major Depression

Depression | Bipolar Disorder

United States
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects

Type II Diabetes
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder

Panic Disorder

United States
Reinier de Graaf Groep

Not yet recruiting

REDucing Hot FLASHes in Women Using Endocrine Therapy. (REDFLASH)

Breast Cancer | Hot Flash Due to Medication
New York State Psychiatric Institute
Columbia University

Recruiting

Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer (IPT)

Breast Cancer | Major Depressive Disorder | Venlafaxine

United States
Haseki Training and Research Hospital

Completed

Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine

Vestibular Migraine

Turkey
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder

Social Phobia

United States, Canada
National Cheng-Kung University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)

Unknown

Pharmacogenomics Studies of Antidepressants

Major Depressive Disorder | Pharmacogenetics | Antidepressive Agents | Fluoxetine | Venlafaxine

Taiwan
Centre for Addiction and Mental Health
Ontario Mental Health Foundation

Completed

Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression

Depression | Major Depressive Disorder

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Anxiety Disorders

United States
Eli Lilly and Company

Completed

Duloxetine vs. Active Comparator for the Treatment of Depression

Depression

Canada
Mayo Clinic
Abbott Medical Devices

Completed

Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)

Polycystic Ovary Syndrome

United States
Abbott Medical Devices

Active, not recruiting

Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)

Neuropathic Pain | Refractory Pain | Chronic Low-Back Pain

United States
GlaxoSmithKline

Completed

The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Lithuania, United Kingdom
Centre for Addiction and Mental Health
McMaster University

Completed

CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia (CCI)

Depression | Anxiety | Mild Cognitive Impairment

Canada
Mayo Clinic

Completed

Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy

Peripheral Neuropathy

United States
Max-Planck-Institute of Psychiatry

Completed

Venlafaxine Augmentation in Treatment Resistant Depression

Depression

Germany
Eli Lilly and Company

Completed

Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

Depression

France
Rhodes Pharmaceuticals, L.P.

Completed

Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD (PK003)

Attention-Deficit/Hyperactivity Disorder

United States
Aziende Chimiche Riunite Angelini Francesco S.p.A

Completed

Trazodone Once a Day in Major Depression Disorder

Major Depressive Disorder

Austria, Czech Republic, Italy, Romania, Slovakia, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Anxiety Disorder

Argentina, Australia, Belgium, Canada, Mexico, Russian Federation, Taiwan, United Kingdom
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Healthy

United States
Emory University

Completed

Effects of Treatment on Decision-making in Major Depression

Major Depressive Disorder | Healthy Controls

United States
Beth Israel Deaconess Medical Center
Veloxis Pharmaceuticals

Not yet recruiting

Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

Medication Adherence | Renal Transplant
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
Supernus Pharmaceuticals, Inc.

Completed

Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients

Epilepsies, Partial

United States
University of Washington
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Alkermes, Inc.

Completed

Harm Reduction With Pharmacotherapy (HaRP) (HaRP)

Alcohol Use Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

Panic Disorder

United States
GlaxoSmithKline

Terminated

Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease

Alzheimer's Disease

United Kingdom
Michele Staton
National Institute on Drug Abuse (NIDA)

Completed

Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder

Opioid Dependence

United States
University of Minnesota

Withdrawn

Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study

Obesity | Insulin Resistance
University of California, Los Angeles
Alkermes, Inc.

Completed

Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) (IPOD)

Opioid Use Disorders

United States
Duke University
National Institute of Mental Health (NIMH)

Completed

Treatment of Obsessive Compulsive Disorder in Children

Obsessive-Compulsive Disorder

United States
Mendel AI
Cairo University

Unknown

The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy | Oncology Pain

Egypt
New York State Psychiatric Institute
National Institute on Aging (NIA)

Completed

Combination Treatment Study for Memory Impairment and Depression (DEP-CI)

Depression | Mild Cognitive Impairment

United States
Capital Medical University

Completed

Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression

Major Depression

China
Turku University Hospital

Completed

Effect of Duloxetine and Venlafaxine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol: A Three-phase Randomized Balanced Cross-over Study in Healthy Volunteers

Healthy

Finland
AstraZeneca

Completed

Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone (RECOVER)

Schizophrenic Disorders

Brazil, Bulgaria, Russian Federation, Turkey, Germany, Romania, Finland, Belgium, Italy, Portugal, Mexico, Spain, Costa Rica, Switzerland
University of Campinas, Brazil

Unknown

Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma (METDEXA-MM)

Multiple Myeloma

Brazil
Janssen Research & Development, LLC

Completed

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Healthy

United States
University of Wisconsin, Madison
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Brain Imaging Techniques That Predict Antidepressant Responsiveness (WyethKolden)

Major Depressive Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder

Panic Disorders

Brazil
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Indiana Hemophilia &Thrombosis Center, Inc.

Active, not recruiting

Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency

Plasminogen Activator Inhibitor-1 Deficiency | Cardiac Fibrosis

United States
Handok Inc.

Completed

A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mg

Healthy Volunteers

Korea, Republic of
Brigham and Women's Hospital
Arthritis Foundation

Recruiting

Preventing Injured Knees From osteoArthritis: Severity Outcomes (PIKASO)

Osteoarthritis, Knee | Post-traumatic Osteoarthritis | ACL Tear

United States

Search clinical trials for: Venlafaxine-XR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations